Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients.

@article{Stevens1997ThalidomideIT,
  title={Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients.},
  author={Roger J. G. Stevens and Carlos And{\'u}jar and Christopher J. Edwards and Paul Richard Julian Ames and Angela Barwick and Munther A. Khamashta and Graham R. V. Hughes},
  journal={British journal of rheumatology},
  year={1997},
  volume={36 3},
  pages={353-9}
}
We review the efficacy, tolerability and safety of low-dose thalidomide in the treatment of refractory disfiguring rash in 16 patients with cutaneous manifestations of lupus. Rashes, which included discoid lupus erythematosus (DLE), subacute cutaneous lupus (SCLE), photosensitive malar rash and non-specific chronic erythema, were diagnosed on clinical grounds, supported by skin biopsy in 11/16 patients. Using starting doses of 50-100 mg/day, 7/16 (44%) patients gained complete or near-complete… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

Similar Papers

Loading similar papers…